ShareValue scores for AMANTA.NSE: Valuation 56, Quality 52, Growth 47, Health 34.

AMANTA.NSE
NSE

AMANTA

₹164.13(+4.99%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 17%
Valuation
56
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
34
Stressed
Financial Stability
Momentum
85
Bullish
Price Trend

Company Details

About

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, leur-lock, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 18, 2026
|
Last calculated:Aug 18, 2026